{"name":"Curia","slug":"curia","ticker":"PRIVATE","exchange":"Private (GTCR-owned)","domain":"curiaglobal.com","description":"Curia in ancient Rome referred to one of the original groupings of the citizenry, eventually numbering 30, and later every Roman citizen was presumed to belong to one. While they originally probably had wider powers, they came to meet for only a few purposes by the end of the Republic: to confirm the election of magistrates with imperium, to witness the installation of priests, the making of wills, and to carry out certain adoptions.","hq":"Albany, NY, USA","founded":0,"employees":"","ceo":"Philip Macnabb","sector":"CDMO / Integrated Small & Large Molecule","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"~$2.5B (GTCR valuation)","metrics":{"revenue":850000000,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2028-06-01","label":"Lupin's generic version of Humira patent cliff ($10.8B at risk)","drug":"Lupin's generic version of Humira","type":"patent_expiry","sentiment":"negative"},{"date":"2029-06-01","label":"Sandoz's generic version of Enbrel patent cliff ($5.5B at risk)","drug":"Sandoz's generic version of Enbrel","type":"patent_expiry","sentiment":"negative"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[{"date":"2024-02-15","type":"deal","headline":"Curia Acquires Catalent's Clinical Supply Business","summary":"Curia has acquired Catalent's clinical supply business, expanding its capabilities in clinical supply chain management.","drugName":"","sentiment":"positive"},{"date":"2023-08-01","type":"earnings","headline":"Curia Reports Strong Q2 2023 Earnings","summary":"Curia reported strong Q2 2023 earnings, driven by increased demand for its development and manufacturing services.","drugName":"","sentiment":"positive"}],"realNews":[{"url":"https://news.google.com/rss/articles/CBMipwFBVV95cUxNbnM3ZlBaUG5vZFJha2NpLWVNMVZWc3RNRzR3NzFhSnh5U0JaaE1QU3FuLUhNdFM3OGxULXVZY1JUTnJPcFVYc0h2OTB6WTBTSWk4ZnVfOEVpdHF0WWVwOTJENU9FcG8wRUV3TG1JY3otOE1rb1ozcHpRcDNpb3Zfdlp6UUVndlhNc2xJYi0zSEMxTHpMRFFqV0Y4NTdEZEctX2tYZjlEZw?oc=5","date":"2025-08-23","type":"pipeline","source":"Times Union","summary":"Albany area drugmaker Curia hit by federal funding cut - Times Union","headline":"Albany area drugmaker Curia hit by federal funding cut","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMioAFBVV95cUxNaHBJRXB3NXIycjY5d0pEOTRwX3lZanJwaDI4TGt0Tl93T2FCM1k3TmQyRHB0aFhLM2dMS2E1UEVtU2p4SDMzTFRDWXB6bUo2NmVUa1c0SE5aMm0yUzNNWmVkdDlPbFdYUFVLWG5pVWxEdzZxZVZIbjlhemJzNVpJaS1IQnBPN1RVVjBmVnM2aXRLaE91STl0cURGaF9FM3NE?oc=5","date":"2025-07-16","type":"pipeline","source":"RegMedNet","summary":"Beyond the Genome: Private Equity’s Playbook for the Next Biotech Frontier - RegMedNet","headline":"Beyond the Genome: Private Equity’s Playbook for the Next Biotech Frontier","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiiwFBVV95cUxPNHliZzFTVmNPYVpjQ0NnRkJlYjlINkhiZmZTWEFRUWlMM19TdE1iRGh4RXZ3LXFtU0JZM3I2LXBST1dQeEFKMmlNR21BWGVTbkFSdFBnSWFCdkFtRUwyLTJJcVhtaDVEXzhYOGJ1bk9hQmNHcnlVcUJDVDBid2ZqQVNpQkZ3QWNHYy13?oc=5","date":"2023-12-05","type":"pipeline","source":"Yahoo Finance","summary":"Curia Recognized on India Pharma Outlook’s 2023 List of Top 10 CDMO Companies in India - Yahoo Finance","headline":"Curia Recognized on India Pharma Outlook’s 2023 List of Top 10 CDMO Companies in India","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimAFBVV95cUxOUUx4SEdneDFmTkg5YlJiLXRmbGdmX3dHX1c2MnZXc2dVLWdEUVlGX1NINDA3ZS1WVzBzeVdFdUw2TDJhaURnbmhUZElTVkhQMFE1M05GZjlyZmJCSkFiN0xDYTNHbmhMUEJ4dEVvVDloczd1eWhlSXIzQ1ZHenJ2bmNXeGZoeEJ5WWZfWkZtb3lMUlEta2p3NA?oc=5","date":"2023-10-15","type":"pipeline","source":"C&EN","summary":"Private equity ramps up in pharmaceutical services - C&EN","headline":"Private equity ramps up in pharmaceutical services - C&EN","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirAFBVV95cUxQM2V4SC1ZTm9QT01YbzFqcVk3LW0wa21lcTlJSnBKWHNXYUFjQ3UtSS1IblBLRTluTjJabW1LcGpDWlRKazU3OHJjVWJzaVhjekhzdW9Hd1QzZUJPOWU5TFhRYUtjLTYwMjg2QlNxUlhSZXNRSUhnMGhIdGlzQmVYSEJDaHVGejRDVmVMWndwb1pDYzNqX24tRVVaYnE1aGJGN2VBZUgtc0l5bHI2?oc=5","date":"2023-09-15","type":"pipeline","source":"Genetic Engineering and Biotechnology News","summary":"Top 10 Contract Development and Manufacturing Organizations - Genetic Engineering and Biotechnology News","headline":"Top 10 Contract Development and Manufacturing Organizations","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikwFBVV95cUxPUUJzVUVUU24zN0QxZlNIUkR3b1RvWDFmU1lBVFZyUklxUmVRbHRhWHFNcUNZSXJNZUlsbnR6cXBJelZUaEVxZ2JmU2FnVDhiTjRsWDRhZWRzX2Y2LXpYNU9RR0Y1anUwa2FsWkZNUWo2Q3MxaFdMMHotUHh4c0huQlRvbzJQVW5VUnhfQ2owSXlsekk?oc=5","date":"2022-03-10","type":"deal","source":"Fierce Pharma","summary":"Curia set to expand in New Mexico thanks to injectable supply deal with US government - Fierce Pharma","headline":"Curia set to expand in New Mexico thanks to injectable supply deal with US government","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikwFBVV95cUxNSmplQ29HWmY4eWdST0dHbk1Ddm5iaHM1cmY0X1YtRGt4ZEhyblhlb1RHdnVwb3cxb3RoQmlRc2phbTMyTktzUEU0RzN4ZmV5VFFjTWhGamUzNmYxRmFscVktQ1hUX1Z5NzNZd3Y4OXkzeDZUQjJTbFFNNjJtQWFHX2FRUDRqYkt1TkdoOEE1bklwLWs?oc=5","date":"2021-09-06","type":"pipeline","source":"Manufacturing Chemist","summary":"Curia completes acquisition of US CDMO LakePharma - Manufacturing Chemist","headline":"Curia completes acquisition of US CDMO LakePharma","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMioAFBVV95cUxPQVJwNDQ1RXA1YXA5bHFKSTROejg5bjlsTkJfWXQwZkhQeUUwcUE4dUhua3dGV3Rza0NIR3g3MWh1XzRPbDFZNlo5Q2l4bE5wb3dPem5EV09LWjA0WHQxbk5oZEM4bTk2RlRRMUd2UDgwQUxkX0pkMTNmby1kQ2JKWHMwQ3A4RVVVMy1mMXNQcXJiUlY5WmhFTTgxeTJQSFFM?oc=5","date":"2021-07-14","type":"pipeline","source":"PitchBook","summary":"PE-backed pharma R&D company Curia eyes $500M takeover of two rivals - PitchBook","headline":"PE-backed pharma R&D company Curia eyes $500M takeover of two rivals","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMizwFBVV95cUxQdzBLcXFqbXQtUFc2ZW15SVNkLUxiX1BJZFdrOHdPa0pKbXNENG5FOGJNRkdwbGlNVUFFbEVWcG83QTVmREd6ampsMnJobU85aDk2Uk1HNmRNOEVwMVBYVWJLdkZPZUlXWWk5c0RkTWIyZ1pldWgtNURlaHdKWUNvTHZKZkt2X21vU2dRSmNiRzJReDkxV1hOX3ZNT25PVENQMXoweVBUSFhlM2Jxal9CcjM1Y2c0RnRDeDdiaVpQbnJERk8xeE5kV2ZoVnF6OHc?oc=5","date":"2021-07-14","type":"deal","source":"Summit Partners","summary":"Curia to Acquire US-based LakePharma, Expanding End-to-End R&D Capabilities and Scale for Biologics - Summit Partners","headline":"Curia to Acquire US-based LakePharma, Expanding End-to-End R&D Capabilities and Scale for Biologics","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirwFBVV95cUxPbVJpLVA0dDEwVlFkd2tnakZWRUZJVzRYVHpNT2N2d0pxUEdEMzBpS093dVVxYzdEaTllSGNvQzk4M2t4WWZGOFZ0NkJpaHpaMFZEUXJ3QTE5dldmUkttSnF4bzlYanNtZHNXZ1MzNlRBM0NCaEVvLTRSMGlhYUcycUdCTWh5MW1GVFZvb1NheU8tVUxieFhLZkJUOUd2c24tZ2k3NHpibHN1TTIzSXJ3?oc=5","date":"2021-07-14","type":"deal","source":"BioProcess International","summary":"Curia buying LakePharma and Integrity - BioProcess Insider - BioProcess International","headline":"Curia buying LakePharma and Integrity - BioProcess Insider","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijwFBVV95cUxOcGVVR0kxTnRZOFVnMUlmYzRCaHVTWXBWRU9mUE02ejZNM1ZYLXpEX0x6alJUVXhsa1ozZkFRWGZXcnhKeVRGaVJkN2didHlVZ2R3bk1WU0czZWlRSDh0X2ZSU182RWhpeWRoT0JnVkk0VHk0a2JCYTlYeTMzVmR4OTc2akJBMkllVkJmSGxzOA?oc=5","date":"2021-07-14","type":"pipeline","source":"The Business Journals","summary":"Curia, formerly AMRI, announces second biopharma acquisition in a week - Albany Business Review - The Business Journals","headline":"Curia, formerly AMRI, announces second biopharma acquisition in a week - Albany Business Review","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMisgFBVV95cUxQRG56MjI5Nm5zUGJ6bzJhQlJaOTlIbHJyYUFIaUhNd05hUEJZMkNNZjlmWVZYZy1HeW1nZVE2R1pKWTFUUnl1X2ZINE9DSmVCUUxjRGpXeHZ0VVV0cVhLRThlaE1UNmNnZFdESG1JSGgwbDh3VjdhbzI1dDBsZERnSGVWZnJZellldDdSRmxCY2VGQmpIN0w0WGg2eU1ET0dYSUxnNGhDM3hzQTRJWDJnNE5n?oc=5","date":"2021-07-12","type":"deal","source":"Bloomberg.com","summary":"Carlyle’s Curia Said in Talks to Buy LakePharma, Integrity Bio - Bloomberg.com","headline":"Carlyle’s Curia Said in Talks to Buy LakePharma, Integrity Bio","sentiment":"neutral"}],"patents":[{"drugName":"Lupin's generic version of Humira","drugSlug":"adalimumab","patentNumber":"","type":"Patent Cliff","expiryDate":"2028-06-01","territory":"US","annualRevenue":10800000000},{"drugName":"Sandoz's generic version of Enbrel","drugSlug":"etanercept","patentNumber":"","type":"Patent Cliff","expiryDate":"2029-06-01","territory":"US","annualRevenue":5500000000}],"drugCount":0,"phaseCounts":{},"enrichmentLevel":3,"visitCount":2,"keyCompetitors":["Catalent","Lonza","Piramal"],"therapeuticFocus":["Oncology","Autoimmune Disorders"],"financials":null,"yahoo":null}